
Serc - Uses, Side Effects, Interactions - MedBroadcast.com
Betahistine belongs to a group of medications used to treat vertigo associated with Ménière's disease. Vertigo is a condition that causes sufferers to have a sensation of rotation or movement of themselves or their surroundings.
What is betahistine used for? - Drugs.com
2024年11月14日 · Betahistine is used to treat symptoms of Meniere’s disease, a condition of the inner ear that can cause symptoms such as dizziness, nausea, vertigo (a spinning sensation), ringing in the ears (tinnitus), and hearing loss.
Serc Dosage & Drug Information | MIMS Philippines
Discover concise prescribing info for Serc topical on MIMS including its uses, special precautions, interactions, dosages etc.
Serc: Uses, Dosage, Side Effects, Food Interaction & FAQ
2025年1月7日 · Serc Mesilate dilates precapiilary sphincters, increasing the blood flow in the inner ear. It controls the permeability of capillaries in the inner ear, thereby removes endolymphatic hydrops. It also improves cerebral circulation, increasing blood flow in …
Consumer Information for: SERC - Drug and Health Products Portal
SERC ® is used for reducing the episodes of recurrent vertigo (dizziness) associated with Ménière’s disease. What it does SERC ® is a type of medicine called a histamine-analogue.
Serc† is the brand name for a drug called “betahistine dihydrochloride”. Serc is used for reducing the episodes of recurrent vertigo associated with Meniere’s disease.
Betahistine: a medicine to treat Ménière's disease - NHS
Find out how betahistine treats symptoms of Ménière's disease and how to take it. NHS medicines information on betahistine – what it's used for, side effects, dosage and who can take it.
SERC - Solvay Pharma
Serc® (Betaserc®, Vasomotal®, betahistine dihydrochloride) of Solvay Pharmaceuticals is the world market leader in the treatment of Ménière’s disease and vestibular vertigo. Serc® was first registered in Europe in 1970 for the treatment of Ménière’s disease.
SERC® (betahistine dihydrochloride) is indicated for: reducing the episodes of recurrent vertigo associated with Ménière’s disease. Geriatrics (> 65 years of age):
Serc contains the active ingredient betahistine dihydrochloride. It belongs to a group of medicines to help treat vertigo. Serc works by improving the blood flow of the inner ear and restoring it to normal. It also acts on the nerve endings in the inner ear to normalise the way in which the nerves respond to outside influences.
- 某些结果已被删除